Hofseth BioCare ASA
HOFBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $468,038 | $682,580 | $1,208,714 | $2,388,050 |
| - Cash | $25,577 | $20,871 | $29,881 | $47,211 |
| + Debt | $170,880 | $280,789 | $104,167 | $139,182 |
| Enterprise Value | $613,341 | $942,498 | $1,283,000 | $2,480,021 |
| Revenue | $257,417 | $194,874 | $120,448 | $87,616 |
| % Growth | 32.1% | 61.8% | 37.5% | – |
| Gross Profit | $87,864 | $44,186 | $28,514 | $23,099 |
| % Margin | 34.1% | 22.7% | 23.7% | 26.4% |
| EBITDA | -$67,941 | -$62,728 | -$97,008 | -$87,720 |
| % Margin | -26.4% | -32.2% | -80.5% | -100.1% |
| Net Income | -$123,405 | -$106,683 | -$137,389 | -$126,463 |
| % Margin | -47.9% | -54.7% | -114.1% | -144.3% |
| EPS Diluted | -0.3 | -0.27 | -0.37 | -0.35 |
| % Growth | -11.1% | 27% | -5.7% | – |
| Operating Cash Flow | -$9,818 | $2,761 | -$45,168 | -$61,779 |
| Capital Expenditures | -$4,073 | -$14,062 | -$17,778 | -$37,751 |
| Free Cash Flow | -$13,891 | -$11,301 | -$62,946 | -$99,530 |